Cargando…
Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignancies worldwide. Checkpoint blockade immunotherapy has made tremendous progress in the treatment of a variety of cancers in recent years. Costimulatory molecules constitute the foundation of cancer immunothera...
Autores principales: | Aye, Ling, Song, Xiaole, Yang, Jingyi, Hu, Li, Sun, Xicai, Zhou, Jiaying, Liu, Quan, Yu, Hongmeng, Wang, Dehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381651/ https://www.ncbi.nlm.nih.gov/pubmed/34434928 http://dx.doi.org/10.3389/fcell.2021.695533 |
Ejemplares similares
-
A nomogram for predicting overall survival of patients with sinonasal melanoma: A population‐based study
por: Yang, Jingyi, et al.
Publicado: (2022) -
Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022) -
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020) -
Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022) -
The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma
por: Liao, Peng, et al.
Publicado: (2019)